Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90

Journal of Hepatology

Volumn 40, Issue 1, 2004, Pages 52-59

  Sakata, Ryuichiro ^a   Ueno, Takato ^a   Nakamura, Toru ^a   Sakamoto, Masaharu ^a   Torimura, Takuji ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell signal transduction; Liver cirrhosis; Liver fibrosis

Indexed keywords

ANTIMITOTIC AGENT; BROXURIDINE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; EPIGALLOCATECHIN GALLATE; IODINE 125; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR RECEPTOR; POLYPHENOL; RADIOLIGAND; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB;

ARTICLE; AUTOPHOSPHORYLATION; BINDING ASSAY; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEPTOR BINDING; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; TEA;

EID: 0347950970     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00477-X     Document Type: Article

References (36)

1. Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 1997;32:424-430.
2. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999;19: 129-140.
3. Godichaud S, Krisa S, Couronne B, Dubuisson L, Merillon JM, Desmouliere A, et al. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 2000;31:922-931.
4. Stickel F, Brinkhaus B, Krahmer N, Seitz HK, Hahn EG, Schuppan D. Antifibrotic properties of botanicals in chronic liver disease. Hepatogastroenterology 2002;49:1102-1108.
5. Stensvold I, Tverdal A, Solvoll K, Foss OP. Tea consumption, relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 1992;21:546-553.
6. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-1011.
7. Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med 1999;159:2170-2174.
8. Sachinidis A, Skach RA, Seul C, Ko Y, Hescheler J, Ahn HY, et al. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. Faseb J 2002;16:893-895.
9. Ahn HY, Hadizadeh KR, Seul C, Yun YP, Vetter H, Sachinidis A. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell 1999;10:1093-1104.
10. Yang CS, Chung JY, Yang G, Chhabra SK, Lee MJ. Tea and tea polyphenols in cancer prevention. J Nutr 2000;130:472S-478S.
11. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37:693-704.
12. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998;18:2-13.
13. Murakami K, Abe T, Miyazawa M, Yamaguchi M, Masuda T, Matsuura T, et al. Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest 1995;72:731-739.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
15. Peterson GL. Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. Anal Biochem 1979;100: 201-220.
16. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999;270:41-49.
17. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.
18. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
19. Inui H, Kitami Y, Tani M, Kondo T, Inagami T. Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. J Biol Chem 1994;269:30546-30552.
20. Inui H, Kitami Y, Kondo T, Inagami T. Transduction of mitogenic activity of platelet-derived growth factor (PDGF) AB by PDGF-beta receptor without participation of PDGF-alpha receptor in vascular smooth muscle cells. J Biol Chem 1993;268:17045-17050.
21. Yamane T, Hagiwara N, Tateishi M, Akachi S, Kim M, Okuzumi J, et al. Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn J Cancer Res 1991;82: 1336-1339.
22. Nishida H, Omori M, Fukutomi Y, Ninomiya M, Nishiwaki S, Suganuma M, et al. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn J Cancer Res 1994;85:221-225.
23. Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 2000;71:1698S-1702S.
24. Lu LH, Lee SS, Huang HC. Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK. Br J Pharmacol 1998;124:1227-1237.
25. Locher R, Emmanuele L, Suter PM, Vetter W, Barton M. Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. Eur J Pharmacol 2002; 434:1-7.
26. Hwang KC, Lee KH, Jang Y, Yun YP, Chung KH. Epigallocatechin-3-gallate inhibits basic fibroblast growth factor-induced intracellular signaling transduction pathway in rat aortic smooth muscle cells. J Cardiovasc Pharmacol 2002;39:271-277.
27. Khafif A, Schantz SP, Chou TC, Edelstein D, Sacks PG. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 1998;19:419-424.
28. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3- gallate. J Cell Biochem 1999;75:1-12.
29. Ahmad N, Cheng P, Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 2000;275:328-334.
30. Kawada N, Ikeda K, Seki S, Kuroki T. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. J Hepatol 1999;30:1057-1064.
31. Marra F, Gentilini A, Pinzani M. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology 1997;112:1297-1306.
32. Chen A, Zhang L. The antioxidant (-)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factor-beta receptor. J Biol Chem 2003;278: 23381-23389.
33. Ueki N, Ohkawa T, Yamamura H, Takahashi K, Tsutsui T, Kawai Y, et al. Induction of calponin-hl by transforming growth factor-beta1 in cultured human ito cells, LI90. Biochim Biophys Acta 1998;1403: 28-36.
34. Matsuura T, Hasumura S, Nagamori S, Murakami K. Retinol esterification activity contributes to retinol transport in stellate cells. Cell Struct Funct 1999;24:111-116.
35. Cheng J, Imanishi H, Liu W, Iwasaki A, Ueki N, Nakamura H, et al. Inhibition of the expression of alpha-smooth muscle actin in human hepatic stellate cell line, LI90, by a selective cyclooxygenase 2 inhibitor, NS-398. Biochem Biophys Res Commun 2002;297:1128.
36. Ozaki I, Zhao G, Mizuta T, Ogawa Y, Hara T, Kajihara S, et al. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 2002;36:169-178.